Cryoglobulinemic vasculitis
MONDO:0007407Mixed cryoglobulinemia (MC) is a rare multisystem disease characterized by the presence of circulating cryoprecipitable immune complexes in the serum, manifested clinically by a classical triad of purpura, weakness and arthralgia.
Also known as: MC, Mixed Cryoglobulinemia, essential cryoglobulinemia, essential mixed cryoglobulinemia, mixed cryoglobulinemia, primary cryoglobulinemia, Meltzer syndrome, cryoglobulinemia, familial mixed
6 clinical trials for this condition and its sub-types, 4 tagged with Cryoglobulinemic vasculitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cryoglobulinemic vasculitis
-
Mixed cryoglobulinemia type III 0 trials
-
Type II mixed cryoglobulinemia 0 trials
-
New hope for rare vasculitis: obinutuzumab steps in where rituximab fails
Disease control Recruiting nowThis phase 2 trial tests obinutuzumab, a drug similar to rituximab but possibly stronger, in 30 adults with active cryoglobulinemic vasculitis who did not improve or could not tolerate rituximab. The goal is to see if obinutuzumab can bring the disease under control and allow pat…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Pregnancy and vasculitis: new study seeks answers
Knowledge-focused Recruiting nowThis study tracks the pregnancy experiences of women with vasculitis, a group of rare diseases causing blood vessel inflammation. Researchers will use online surveys to understand how vasculitis affects pregnancy and what outcomes occur. The goal is to gather information to help …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Skin biopsies shed light on rare blood vessel disease
Knowledge-focused Recruiting nowThis study looks at skin samples from 50 people with different types of vasculitis, a condition where blood vessels become inflamed. Researchers want to understand how the disease affects the skin at a molecular level. Participants must have an active skin rash related to their v…
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC